期刊文献+

甲状旁腺素非PLC依赖PKC通路激活增强成骨细胞CITED1表达 被引量:5

Activation of phospholipase C-independent protein kinase C signaling pathway of parathyroid hormone enhances CITED1 expression in mouse osteoblasts
下载PDF
导出
摘要 目的:通过相关信号通路屏蔽和基因表达分析,探讨甲状旁腺素(PTH)非PLC依赖PKC信号转导途径(PTH/nonPLC/PKC)的功能,分析其对骨代谢的影响。方法取2-3 d C57BL乳鼠颅盖骨分离培养成骨细胞,取贴壁生长的第1代细胞,随机分为4组:100 nmol/L[Gly1, Arg19]hPTH(1-28)(简称GR(1-28))+10 nmol/L RP-cAMP;10 nmol/L[Gly1, Arg19]hPTH(1-34)(简称GR(1-34))+10 nmol/L RP-cAMP;10 nmol/L PTH(1-34)及空白对照组加入等体积的0.1%三氟乙酸(trifluoroacetic acid, TFA),作用4 h后,提取各组总RNA,行小鼠全基因组表达谱芯片分析,筛选出可能与nonPLC/PKC信号转导通路相关的差异表达基因,并进行相关通路分析。RT-PCR筛选及验证上述差异表达基因。培养MC3T3-E1细胞,分为4组:GR(1-28)+RP-cAMP;GR(1-34)+RP-cAMP;GR(1-34)+RP-cAMP+100 nmol/L Go6983及空白对照组,RT-PCR法验证比较GR(1-28)和GR(1-34)引起的基因表达变化情况。结果倒置相差显微镜观察示,培养7 d见细胞排列紧密,为三角形或多边形,呈铺路石样;细胞培养14 d ALP染色可见胞质中出现蓝染颗粒,成骨诱导培养28 d茜素红染色可见红色矿化结节形成。基因芯片分析结果中筛选出与PTH的nonPLC/PKC信号转导通路相关性最大的56个基因,进行RT-PCR验证后发现CITED1的表达量在GR(1-34)+RP-cAMP组显著高于GR(1-28)+RP-cAMP组及空白对照组,但小于PTH(1-34)组(P〈0.05)。MC3T3-E1细胞RT-PCR验证的结果与其一致,在阻断cAMP/PKA信号通路后,仅CITED1基因表达量在GR(1-28)和GR(1-34)刺激时存在显著不同,且加入PKC抑制剂(Go6983)后,表达差异消失。结论 PTH的nonPLC/PKC信号转导通路的激活能够使得成骨细胞CITED1的表达量明显升高,介导PTH对成骨代谢的作用。该途径不依赖PLC和PKA信号的激活。 Objective To explore the functions of phospholipase C (PLC)-independent protein kinase C signaling pathway (PTH/nonPLC/PKC) of parathyroid hormone (PTH) and its role in bone metabolism. Methods Osteoblasts isolated from the calvaria of 2-or 3-day-old C57BL mice, identified by alkaline phosphatase staining and Alizarin red staining, were treated for 4 h with 100 nmol/L[Gly1, Arg19]hPTH(1-28) plus 10 nmol/L RP-cAMP, 10 nmol/L[Gly1, Arg19]hPTH(1-34) plus 10 nmol/L RP-cAMP , 10 nmol/L PTH(1-34), or and 0.1% trifluoroacetic acid (TFA). The total RNA was then isolated for screening differentially expressed genes related to PTH/nonPLC/PKC pathway using Affymetrix mouse 12x135K gene expression profile microarray, and the identified genes were confirmed by real-time quantitative PCR. MC3T3-E1 cells treated with[Gly1, Arg19]hPTH(1-28)+RP-cAMP,[Gly1, Arg19]hPTH(1-34)+RP-cAMP,[Gly1, Arg19]hPTH(1-34)+RP-cAMP+100 nmol/L Go6983, or 0.1%TFA were also examined for GR(1-28)-or GR(1-34)-mediated gene expression changes using real-time quantitative PCR. Results Alizarin red staining visualized red mineralized nodules in the osteoblasts at 28 days of culture. According to the genechip results, we selected 56 target genes related to PTH/nonPLC/PKC pathway, among which CITED1 showed higher expressions in[Gly1, Arg19]hPTH(1-34)+RP-cAMP group than in both the control group and[Gly1, Arg19]hPTH(1-28)+RP-cAMP group (P〈0.05), and its expression was the highest in PTH(1-34) group (P〈0.05). RT-PCR of MC3T3-E1 cells yielded consist results with those in the primary osteoblasts, and the cells treated with Go6983 (a PKC inhibitor) did not show GR(1-28)- or GR(1-34)-mediated differential expression of CITED1. Conclusion The activation of PLC-independent protein kinase C signaling pathway of PTH enhances the expression of CITED1 in mouse osteoblasts to mediate the effect of PTH on bone metabolism, and this pathway is not dependent on the activation of PLC or PKA signaling.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2015年第4期486-491,共6页 Journal of Southern Medical University
基金 国家自然科学基金(30973061 81272043)~~
关键词 甲状旁腺素 信号转导通路 成骨细胞 基因芯片 CITED1 parathyroid hormone signaling pathway osteoblasts genechip
  • 相关文献

参考文献27

  • 1Deal C. Potential new drug targets for osteoporosis[J]. Nat Clin Pract Rheumatol, 2009, 5(1): 20-7.
  • 2Pennisi A, Ling W, Li X, et al. Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone [J]. PLoS One, 2010, 5(12): e15233.
  • 3Kraenzlin ME, Meier C. Parathyroid hormone analogues in the treatment of osteoporosis[J]. Nat Rev Endocrinol, 2011, 7 (11): 647-56.
  • 4Tseng YY, Su CH, Lui TN, et al. Prospective comparison of the therapeutic effect of teriparatide with that of combined vertebroplasty with antiresorptive agents for the treatment of new-onset adjacent vertebral compression fracture aider percutaneous vertebroplasty [J]. Osteoporos Int, 2012, 23 (5): 1613-22.
  • 5Oteo-Alvaro A, Matas JA, Alonso-Farto JC. Teriparatide (rh {[} 1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening[J]. Orthopedics, 2011, 34(9): E574-7.
  • 6Zati A, Sarti D, Malaguti MC, et al. Teriparatide in the treatment of a loose hip prosthesis[J]. J Rheumatol, 2011, 38(4): 778-80.
  • 7Wang J, Gilchrist A, Stem PH. Antagonist minigenes identify genes regulated by parathyroid hormone through G protein-selective and G protein co-regulated mechanisms in osteoblastic cells [J]. Cell Signal, 2011, 23(2): 380-8.
  • 8Yang D, Guo J, Divieti P, et al. Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway[J]. Bone, 2006, 38(4): 485-96.
  • 9Guo J, Liu M, Yang D, et al. Phospholipase C signaling via the parathyroid hormone (PTH)/PTH-related peptide receptor is essential for normal bone responses to PTH [J]. Endocrinology, 2010, 151(8): 3502-13.
  • 10Yang D, Singh R, Divieti P, et al. Contributions of parathyroid hormone (PTH)/PTH-related peptide receptor signaling pathways to the anabolie effect of PTH on bone [J]. Bone, 2007, 40 (6): 1453-61.

二级参考文献49

  • 1Kalive M, Faust JJ, Koeneman BA, et al. Involvement of the PKC family in regulation of early development [J]. Mol Reprod Dev, 2010, 77(2): 95-104.
  • 2Fahrmann M. Targeting protein kinase C (PKC) in physiology and Cancer of the gastric cell system[J]. Curr Med Chem, 2008, 15(12): 1175-91.
  • 3Chang S, Hypolite JA, Mohanan S, et al. Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder [J]. Lab Invest, 2009, 89(7): 823-32.
  • 4Hains AB, Vu MA, Maciejewski PK, et al. Inhibition of protein kinase C signaling protects prefrontal cortex dendritic spines and cognition from the effects of chronic stress[J]. Proc Natl Acad Sci U S A, 2009, 106(42): 17957-62.
  • 5Dossing DA, Radeff JM, Sanders J, et al. Parathyroid hormone stimulates translocation of protein kinase C isozymes in UMR-106 osteoblastic osteosarcoma cells[J]. Bone, 2001, 29(3): 223-30.
  • 6Yang D, Guo J, Divieti P, et al. Parathyroid hormone activates PKC-delta and regulates osteoblastic differentiation via a PLC-independent pathway[J]. Bone, 2006, 38(4): 485-96.
  • 7Robles-Flores M, Rendon-Huerta E, Gonzalez-Aguilar H, et al. p32 (gClqBP) is a general protein kinase C (PKC)-binding protein; interaction and cellular localization of P32-PKC complexes in ray hepatocytes[J]. J Biol Chem, 2002, 277(7): 5247-55.
  • 8Jensen TE, Maarbjerg S J, Rose A J, et al. Knockout of the predominant conventional PKC isoform, PKCalpha, in mouse skeletal muscle does not affect contraction-stimulated glucose uptake[J]. Am J Physiol Endocrinol Metab, 2009, 297(2): E340-8.
  • 9Violin JD, Zhang J, Tsien RY, et al. A genetically encoded fluorescent reporter reveals oscillatory phosphorylation by protein kinase [J]. J Cell Biol, 2003, 161(5): 899-909.
  • 10Gao X, Chen T, Xing D, et al. Single cell analysis of PKC activation during proliferation and apoptosis induced by laser irradiation [J]. J Cell Physiol, 2006, 206(2): 441-8.

共引文献4

同被引文献75

  • 1魏福海,陈伟良.骨纤维异常增殖症组织病理学及其发病机制研究进展[J].临床口腔医学杂志,2005,21(8):507-508. 被引量:7
  • 2Rao RR, Stegemann JP. Cell-based approaches to the engineering of vaseularized bone tissue [J]. Cytotherapy, 2013,15( 11 ) : 1309-1322.
  • 3Yang W, Guo D, Harris MA, et al. Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchvmal stem cells [J]. J Cell Sci. 2013. 126(18) :4085-4098.
  • 4Weng T, Xie Y, Huang J, et al. Inactivation of Vhl in osteochondral progenitor cells causes high bone mass phenotype and protects against age-related bone loss in adult mice [ J]. J Bone Miner Res, 2014,29(4) :820-829.
  • 5Wu X, Wang Q, Kang N. The effects of different vascular carrier patterns on the angiogenesis and osteogenesis of BMSC-TCP-based tissue- engineered bone in beagle dogs [ J ]. J Tissue Eng Regen Med, 2015 37 (11 ):72-81.
  • 6Criscitiello C, Viale G, Gelao L, et al. Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment [J]. Cancer Treat Rev, 2015,41(2) :61-68.
  • 7Nakashima T, Hayashi M, Takayanagi H. New insights into osteoclastog -enic signaling mechanisms [J ]. Trends Endocrinol Metab, 2012,23 ( 11 ) : 582-590.
  • 8Wang J, Chen TY, Qin S, et al. Inhibitory effect of metformin on bone metastasis of cancer via OPG/RANKL/RANK system [ J ]. Med Hypotheses, 2013,81 (5) : 805-806.
  • 9Zhao H, Liu X, Zou H, et al. Osteopretegerin induces podosome disassembly in osteoe|asts through calcium, ERK, and p38 MAPK signaling pathways [J ]. Cytokine, 2015,71 (2) : 199-206.
  • 10Aoyama E, Kubota S, Khattab HM, et al. CCN2 enhances RANKL-induced osteoclast differentiation via direct binding to RANK and OPG [ J ]. Bone, 2015,73 : 242-248.

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部